...
首页> 外文期刊>Human Reproduction >SELECTED ORAL COMMUNICATION SESSION, SESSION 25: TRANSLATIONAL RESEARCH, Monday 4 July 2011 17:00 – 18:00
【24h】

SELECTED ORAL COMMUNICATION SESSION, SESSION 25: TRANSLATIONAL RESEARCH, Monday 4 July 2011 17:00 – 18:00

机译:选定的口腔交流会议,第25届会议:翻译研究,2011年7月4日,星期一17:00 – 18:00

获取原文
           

摘要

Introduction: Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of assisted reproduction, with a yet unknown pathophysiology. This syndrome appears to be induced by an ovarian release of vasoactive, angiogenic substances, mainly vascular-endothelial-growth-factor (VEGF). Several OHSS-managing treatments that affect the VEGF system were suggested; unfortunately, these treatments do not entirely eliminate the risk for OHSS and are associated with undesired side effects.
机译:简介:卵巢过度刺激综合症(OHSS)是潜在的威胁生命的辅助生殖并发症,其病理生理机制尚不清楚。该综合征似乎是由卵巢释放的血管活性血管生成物质(主要是血管内皮生长因子(VEGF))诱发的。提出了几种影响VEGF系统的OHSS管理疗法。不幸的是,这些治疗不能完全消除OHSS的风险,并且会带来不良的副作用。

著录项

  • 来源
    《Human Reproduction》 |2011年第1期|p.37-39|共3页
  • 作者单位

    Assaf Harofeh Medical Center, Infertility and IVF, Zerifin, Israel;

    Tel-Aviv University, Cell and Developmental Biology, Tel-Aviv, Israel;

    Tel-Aviv University, Cell and Developmental Biology, Tel-Aviv, Israel;

    Tel-Aviv University, Cell and Developmental Biology, Tel-Aviv, Israel;

    Assaf Harofeh Medical Center, Infertility and IVF, Zerifin, Israel;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号